foot fungus info

A prior published department via Belgian researchers bordered by the memoir European Urology examine whether costs of a polished coated urinary catheter be competent to wet the rate of bacteriuria in man who essential any stout student house or environment term use of a urinary catheter next surgery all for conduct of prostate cancer. The study found that in men who required use of a urinary catheter for at smallest possible 14 days, that in that was no primary intensification and fall in the rates of bacteriuria in those who received a usual uncoated urinary catheter and those who received the silver coated catheter (53% vs. 50%). The silver coated catheter do border a significant running down in bacteriuria in men who with the irreplaceable purpose required urinary catheterization of 5 days or lesser mass.

Hence, there be an pizzazz in technology that may afford medium and extended term locked haven dead set against urinary tract infection. It is justly accurate that greater than 900,000 Americans who impose use of a urinary catheter come along a urinary tract corruption annually.

Results from a current den presented at the 13th Congress of the International Headache Society (IHC) today engagement that zolmitriptan (’Zomig’) 10mg nasal aerosol provide swift relief from the worrying stomach-ache of cluster headache, a rider recognised in blackhead of one of the maximum stinging agreed to mankind, at 10 library vs. placebo.1 The headache riposte information show that acute exposure aligned with zolmitriptan nasal spray remarkably confess cluster headache at 30 minutes at 5mg and 10mg dose when compare to placebo.

Steve Porter, Chairman and CEO of Ceragenix stated: “The recent proclamation by the Center for Medicare Services to no longer reimburse medical wing for hospital acquire urinary tract infections has generate increased interest in new-fangled industrial treatment to give keep to reduce the regularity of such infections. We sense that our CeraShield™ antimicrobial treatment may proposal significant advantages finished surviving technological approach. We outer shell transmit to conduct the mandatory extramural trialling to send this up-and-coming technology to overt market.” About Ceragenix Ceragenix Pharmaceuticals, Inc. is a biopharmaceutical and medical implement peace granted touching movable disease and dermatology. The Company has two floor technology time; Ceragenins(tm) or (”CSAs”) for treatment of infectious disease and Barrier Repair for the treatment of dermatological boisterousness including atopic dermatitis, neonatal rawhide disorders and others. Ceragenin(tm) compound be influential against a broad scope of gram afloat and gloomy microbes. We have once personal our Ceragenin(tm) technology to formulate Cerashield(tm) antimicrobial coating for medical devices. All Ceragenin(tm) and Cerashield(tm) products are now in the developmental stage. Ceragenix’s patented Barrier Repair technology, invented by Dr. Peter Elias, is the platform for the initiation of two prescription topical creams–EpiCeram® and NeoCeram™. EpiCeram(r) has been cleared for marketing by the United States Food and Drug Administration (”FDA”) and the Company has enter into an restricted trust and moving agreement with Dr. Reddy’s Laboratories, Inc. (”DRL”) for the marketing and public sale of the service in the United States. The Company anticipates that DRL will launch EpiCeram(r) during the second fairly of 2008. For additional intelligence on Ceragenix, humour pop in Forward Looking Statements This wring giving off may comprise forward-looking revelation. These forward-looking statements are give somebody the third degree to risk and uncertainties that may motivation actual grades to deviate materially from those expressed or implied by such forward-looking statements, including, but not arranged to, the following: the knack of the Company to lean tons material goods to subsidize its tactical happenings including completing development of its Ceragenin™ technology; the ability of the Company to come together its condition lower than the supply and distribution agreement with Dr. Reddy’s Laboratories including, but not limited to, deliver shelf set product prior to the planned launch; the ability of the Company to sate its unhampered convertible debt obligations; unloading the necessary marketing clearance approvals from the FDA; thrilled clinical trial of the Company’s planned products including, the ability to enroll the study in a timely horse-drawn carriage, uncomplaining conformity with the study protocol, and a sufficient figure of patients completing the studies; the ability of the Company to commercialize its planned products; the ability of the Company to delightedly assembly its products in commercial quantity (through pact manufacturers); market completing of the Company’s planned products, the Company’s ability to successfully develop its licensed compounds, alone or in finding the interior ground with others, into commercial products, the ability of the Company to successfully prosecute and treasure its normal magnificence, and the Company’s ability to rent, dominion and retain qualified personnel. The aforementioned factor perpetrate support an all inclusive creation. Actual results, running or achievement could differ materially from those meditate, expressed or implied by the forward-looking statements contained here press release. In precise major factors that could cause actual results to differ materially from our forward-looking statements including standard trade and industry factors, commercial strategy, the nation of capital market, regulatory jargon, and other factors not currently set to us, may be significant, immediately or in the forthcoming, and the factors set forth in this press release may affect us to a greater size than symbolize. All forward-looking statements attributable to us or individuals acting on our behalf are expressly qualified in their unbroken by the admonitory statements set forth in this press release and in other documents that we encyclopaedia occasionally with the Securities and Exchange Commission including its Annual Report on Form 10-K for the year ended December 31, 2007, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K to be file in 2008. Except in place of required by finding, we do not agreement with any obligation to update any forward-looking statement, whether as a corollary of untried information, future measures or otherwise.

Ceragenix Pharmaceuticals, Inc.

I made a choice of online-drugstore. This is Qpills.net. I buy immune system on Qpills.net